Having worked for nine years at Quintiles, Rob Nichols joined Phase Forward in 2007, which subsequently became part of Oracle in late 2010. As Senior Director of Oracle Health Sciences Global CRO Partnerships, Rob is responsible for delivering an optimal environment for Oracle’s CRO partners.
Tom Grundstrom is VP,Integrated Processes and Technology at Quintiles In this role, he oversees the design, development and adoption of Quintiles Infosario™,a comprehensive, end to end platform that seamless integrates data, systems, process and people from protocol design through commercialization.
He has +30 yrs of experience in health care, financial services, telecommunications, enterprise software development industries & the government sector, and for the past 10 years he has been the CIO of health care service companies. Currently he is VP of Project Management at ICON Plc.
David Pasirstein, Merck & Co., Inc., United States
Description
Utilizing technology has long been seen as a key tactic to drive efficiencies in the clinical development process. Strategic partnerships see this value amplified as technology becomes an underlying part of the pharma-CRO relationship.
Learning Objectives: Identify key components of strategic relationships Discuss how technologies can help create successful strategic partnerships between pharma companies and CRO Explain how technologies help maintain strategic partnerships and improve communication.